Search for: "Boehringer Ingelheim Pharmaceuticals"
Results 81 - 100
of 252
Sorted by Relevance
|
Sort by Date
13 Oct 2009, 9:59 pm
As part of the effort to encourage these companies to pool their patents, MSF has launched an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to place specific HIV drug patents... [read post]
5 Aug 2011, 6:21 am
Boehringer Ingelheim Pharmaceuticals, Inc., Pfizer, Inc., Pharmacia Corporation and Pharmacia & Upjohn, LLC, Nabil Gazal sued the maker of Mirapex for breach of warranty and failure to warn after he developed a serious gambling problem he ascribed to treatment with Mirapex. [read post]
25 Jan 2014, 9:43 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
25 Aug 2009, 1:30 pm
Boehringer Ingelheim International GmbH v Commissioner of Patents [2001] FCA 647 and Prejay Holdings Ltd v Commissioner of Patents [2003] FCAFC 77 applied. [read post]
3 Mar 2007, 12:50 pm
The government’s complaint alleges that Boehringer Ingelheim Roxane engaged in a scheme to report fraudulent and inflated prices for several pharmaceutical products, knowing that federal health care programs established reimbursement rates based on those reported prices. [read post]
13 Jul 2016, 1:56 pm
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
15 Jan 2015, 3:07 pm
Readers of this blog might recall that one drug maker, Boehringer Ingelheim, hid the uncontrolled bleeding it knew was happening during its trials of Pradaxa, a blood thinner. [read post]
10 Mar 2012, 11:35 am
The manufacturer Boehringer Ingelheim Pharmaceuticals, has made subtle revisions to the warning labels regarding blood loss, without including a "black box" warning that is normally applied to dangerous drugs. [read post]
28 Jan 2014, 11:53 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim Int’l. [read post]
20 Sep 2012, 12:15 pm
Boehringer Ingelheim’s blood-thinning drug Pradaxa (dabigatran etexilate) is a $1 billion industry unto itself. [read post]
TTAB Test: Is "BREATHLESS" Merely Descriptive of Idiopathic Pulmonary Fibrosis Information Services?
29 Nov 2017, 3:29 am
In re Boehringer Ingelheim Pharmaceuticals, Inc., Serial No. 86852106 (November 27, 2017) [not precedential] (Opinion by Judge Frances Wolfson).The Board ignored applicant's feeble double entendre argument, but it agreed with applicant that the USPTO's evidence failed to show that the term "breathless" merely describes the subject services. [read post]
23 Jan 2015, 12:59 pm
Boehringer Ingelheim—the manufacturer of Pradaxa—has paid close to $650 million to resolve the thousands of cases brought against it due to the drug’s harmful bleeding side effects. [read post]
10 Oct 2017, 7:10 am
" Boehringer Ingelheim Pharmaceuticals, Inc. et al v. [read post]
10 Nov 2007, 9:26 pm
Ranbaxy announced Thursday that it and Astellas/Boehringer Ingelheim settled their Hatch-Waxman case concerning generic Flomax (tamsulosin), and that it believes it is the first ANDA filer. [read post]
7 Dec 2010, 2:43 am
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
4 May 2017, 1:00 am
Relevant Judicial Practice Boehringer Ingelheim Pharma GmbH & Co KG v. [read post]
2 May 2012, 11:11 am
According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible. [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
22 Aug 2016, 1:05 pm
About Pradaxa Pradaxa, also known as Dabigatran, is manufactured by Boehringer Ingelheim Pharmaceuticals and is prescribed to help prevent the blood from coagulating or clotting. [read post]
